Home ›
Trademark Categories ›
Pharmaceuticals ›
2017 ›
MY ›
MYYNRIAH
Trademark search for:
MYYNRIAH
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2017-03-27 — Application filed
2017-05-11 — Sn assigned for sect 66a appl from ib
2017-05-13 — Application filed
2017-05-14 — Assigned to examiner
2017-05-16 — Final disposition recorded
2017-05-17 — Application filed
2017-05-17 — Office action issued
2017-06-01 — Office action issued
2017-06-01 — Office action issued
2017-06-17 — Office action issued
2017-07-14 — Teas revoke/app/change addr of atty/dom rep received
2017-07-14 — Attorney/dom.rep.revoked and/or appointed
2017-08-17 — Office action issued
2017-08-31 — Assigned to lie
2017-09-05 — Correspondence received in law office
2017-09-05 — Teas/email correspondence entered
2017-09-06 — Approved for pub - principal register
2017-09-20 — Notification of notice of publication e-mailed
2017-10-04 — Notice of start of opposition period created, to be sent to ib
2017-10-04 — Notification of possible opposition sent to ib
2017-10-10 — Published for opposition
2017-10-10 — Official gazette publication confirmation e-mailed
2017-10-21 — Notification processed by ib
2017-12-26 — Registered-principal register
2018-03-26 — Final disposition recorded
2018-04-02 — Final disposition recorded
2018-04-02 — Final disposition recorded
2018-05-19 — Final disposition recorded
2022-12-26 — Courtesy reminder - sec. 71 (6-yr) e-mailed
2024-07-12 — Cancelled section 71
2024-07-12 — Final status recorded
2025-03-12 — Total invalidation of reg ext protection created
2025-06-04 — Invalidation processed
2025-06-05 — Total invalidation of reg ext protection sent to ib
2025-06-20 — Total invalidation processed by the ib
Owner Information
NOVARTIS AG
NOVARTIS AG
NOVARTIS AG
Correspondent
Maury M. Tepper, III Tepper & Eyster, PLLC
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
